Related Experiment Video

Updated: Jun 11, 2026

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening
05:54

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Published on: September 5, 2018

PI(3)king apart PTEN's role in cancer

Siyuan Zhang1, Dihua Yu

  • 1Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|July 13, 2010
PubMed

Insights

The tumor suppressor PTEN (phosphatase and tensin homolog) counteracts cancer growth by regulating the PI3K/Akt pathway. PTEN loss drives cancer progression and therapeutic resistance, highlighting its importance in targeted cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The tumor suppressor phosphatase and tensin homolog (PTEN) is a critical negative regulator of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway, a key driver of cancer.
  • PTEN also plays roles in genomic stability, DNA repair, stem cell self-renewal, senescence, and cell migration.
  • PTEN mutations and deficiencies are common in human cancers and are linked to advanced tumor stages and resistance to therapies like trastuzumab.

Purpose of the Study:

  • To review current knowledge on PTEN function and its signaling pathways.
  • To discuss the implications of PTEN deregulation in cancer.
  • To explore prospects for PI3K/Akt-targeted cancer therapies.

Main Methods:

  • Literature review of PTEN function, signaling, and clinical relevance.
  • Analysis of PTEN's role in cancer progression and therapeutic resistance.
  • Discussion of current and future targeted therapy strategies.

Main Results:

  • PTEN's canonical role in dephosphorylating PIP3 and its non-canonical roles in DNA repair and cell dynamics are crucial.
  • PTEN deficiency significantly contributes to cancer development, metastasis, and resistance to treatments.
  • Targeting the PI3K/PTEN-Akt axis is a central strategy in developing novel anticancer drugs.

Conclusions:

  • PTEN is a vital tumor suppressor with multifaceted roles beyond its phosphatase activity.
  • Understanding PTEN's complex functions and dysregulation is essential for effective cancer treatment.
  • Rational design of therapies targeting the PI3K/Akt pathway holds promise for overcoming therapeutic resistance and improving patient outcomes.

More Related Videos

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models09:18

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models

Published on: February 3, 2026

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...